| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.08. | IntelGenx Technologies Corp. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | ||
| 23.07. | IntelGenx Technologies Corp. - 8-K, Current Report | ||
| 19.07. | IntelGenx Technologies Corp.: IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process | MONTREAL, July 19, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the "Company" or "IntelGenx") (OTC: IGXT), a leading drug delivery company focused on the development and manufacturing of... ► Artikel lesen | |
| 03.07. | IntelGenx Technologies Corp.: IntelGenx Obtains Preliminary Efficacy Results for the 'BUENA' Montelukast VersaFilm Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease | MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the "Company" or "IntelGenx" a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), has successfully completed the BUENA... ► Artikel lesen | |
| 28.06. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.06.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 28.06.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.06.2024ISIN NameAU000000GUD2 G.U.D.... ► Artikel lesen |
